the pharmacokinetics and endocrine effects of the lhrh analogue buserelin [ d-ser ( tbu ) 6-lhrh ] , released from biodegradable implants , were studied in 14 patients with stage c and d prostate cancer .
C0006456
buserelin
C0023610
lhrh